Evidence map›Paper›PMID 32484547›Full record

ArticleNucleic acids research2020

Nick-seq for single-nucleotide resolution genomic maps of DNA modifications and damage.

Bo Cao, Xiaolin Wu, Jieliang Zhou, Hang Wu, Lili Liu, Qinghua Zhang, Michael S DeMott, Chen Gu, Lianrong Wang, Delin You and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Fission Yeast Mating-Type Switching Motto: "One-for-Two" and "Two-for-One".Microbiology and molecular biology reviews : MMBR · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Bo CaoCollege of Life Sciences, Qufu Normal University, Qufu, Shandong 273165, China.
Xiaolin WuDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Jieliang ZhouKK Research Center, KK Women's and Children's Hospital, 229899, Singapore.
Hang WuDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Lili LiuCollege of Life Sciences, Qufu Normal University, Qufu, Shandong 273165, China.
Qinghua ZhangCollege of Life Sciences, Qufu Normal University, Qufu, Shandong 273165, China.
Michael S DeMottDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Chen GuDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Lianrong WangKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei 430071, China.
Delin YouState Key Laboratory of Microbial Metabolism, Joint International Research Laboratory of Metabolic and Developmental Sciences, and School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai 200030, China.
Peter C DedonDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Center for Environmental Health · USQufu Normal University · CNShanghai Jiao Tong University · CNWuhan University · CNAnhui University · CNKK Women's and Children's Hospital · SGMassachusetts Institute of Technology · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI YAFFE, MICHAEL B · 1985 to 2020
$25.6M
Reaction and Diffusion of NO in Biological SystemsP01CA026731 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESSIGMANN, JOHN M · 1985 to 2018
$25.4M
Supplement: Epigenetics of the Human Gut MicrobiomeR01ES031576 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ALM, ERIC JOHN, DEDON, PETER C · 2019 to 2023
$1.9M
NCI NIH HHS P01 CA026731NIEHS NIH HHS P30 ES002109NIEHS NIH HHS R01 ES031576
6 · The paper itself

Abstract

DNA damage and epigenetic marks are well established to have profound influences on genome stability and cell phenotype, yet there are few technologies to obtain high-resolution genomic maps of the many types of chemical modifications of DNA. Here we present Nick-seq for quantitative, sensitive, and accurate mapping of DNA modifications at single-nucleotide resolution across genomes. Pre-existing breaks are first blocked and DNA modifications are then converted enzymatically or chemically to strand-breaks for both 3'-extension by nick-translation to produce nuclease-resistant oligonucleotides and 3'-terminal transferase tailing. Following library preparation and next generation sequencing, the complementary datasets are mined with a custom workflow to increase sensitivity, specificity and accuracy of the map. The utility of Nick-seq is demonstrated with genomic maps of site-specific endonuclease strand-breaks in purified DNA from Eschericia coli, phosphorothioate epigenetics in Salmonella enterica Cerro 87, and oxidation-induced abasic sites in DNA from E. coli treated with a sublethal dose of hydrogen peroxide. Nick-seq applicability is demonstrated with strategies for >25 types of DNA modification and damage.

Indexed as

Chromosome MappingDNADNA DamageEpigenesis, GeneticEscherichia coliGenome, BacterialGenomic InstabilityHigh-Throughput Nucleotide SequencingHydrogen PeroxideNucleotidesSalmonella entericaSequence Analysis, DNADNAHydrogen PeroxideNucleotides

Identifiers

PMID32484547
PMCPMC7337925
OpenAlexW3031548177

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.